Epigenetic Changes in Cancer Related to DLK1 and GTL2 Genes
Author Information
Author(s): Astuti D, Latif F, Wagner K, Gentle D, Cooper W N, Catchpoole D, Grundy R, Ferguson-Smith A C, Maher E R
Primary Institution: University of Birmingham
Hypothesis
Do methylation alterations within the 14q32 imprinted domain occur in human tumorigenesis?
Conclusion
Hypermethylation of the GTL2 promoter is associated with loss of GTL2 expression and may contribute to tumorigenesis in some human cancers.
Supporting Evidence
- 25% of neuroblastoma tumors showed hypermethylation of the GTL2 promoter.
- 10% of phaeochromocytomas exhibited GTL2 promoter hypermethylation.
- 2.5% of Wilms' tumors had hypermethylation at the GTL2 promoter.
Takeaway
Some genes can get turned off in cancer, and this study found that a specific gene called GTL2 is often turned off in certain tumors.
Methodology
The study used multiplex methylation PCR and bisulphite sequencing to analyze the methylation status of the GTL2 promoter in various tumor samples.
Potential Biases
Potential bias in sample selection and the limited number of tumor types analyzed.
Limitations
The study's findings may not be generalizable to all cancer types due to the specific focus on neuroblastoma, phaeochromocytoma, and Wilms' tumors.
Participant Demographics
The study analyzed 20 neuroblastoma tumors, 20 phaeochromocytomas, and 40 Wilms' tumors.
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website